Pharmaceuticals in Russia

Date: April 30, 2014
Pages: 37
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Brief Review
Delivery: E-mail Delivery (PDF)
ID: PE5AB30CEE9EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Russia
Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Russia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2013 annual average exchange rates.
  • The Russian pharmaceuticals market had total revenues of $17.3bn in 2013, representing a compound annual growth rate (CAGR) of 9.9% between 2009 and 2013.
  • Legislative changes in the Russian health care system have been introduced in recent years, which have meant increased expenditure on pharmaceutical products.
  • The performance of the market is forecast to decelerate, with an anticipated CAGR of 7.6% for the five-year period 2013 - 2018, which is expected to drive the market to a value of $25bn by the end of 2018.
Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Russia

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia

Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Russia economy

Key Questions Answered
  • What was the size of the Russia pharmaceuticals market by value in 2013?
  • What will be the size of the Russia pharmaceuticals market in 2018?
  • What factors are affecting the strength of competition in the Russia pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Russia's pharmaceuticals market?
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Novartis AG
Pharmstandard OJSC
Sanofi SA
Macroeconomic Indicators
Country Data
Appendix
Methodology
Industry associations
Related MarketLine research

LIST OF TABLES

Table 1: Russia pharmaceuticals market value: $ billion, 2009–13
Table 2: Russia pharmaceuticals market geography segmentation: $ billion, 2013
Table 3: Russia pharmaceuticals market share: % share, by value, 2013
Table 4: Russia pharmaceuticals market value forecast: $ billion, 2013–18
Table 5: Bayer AG: key facts
Table 6: Bayer AG: key financials ($)
Table 7: Bayer AG: key financials (€)
Table 8: Bayer AG: key financial ratios
Table 9: Novartis AG: key facts
Table 10: Novartis AG: key financials ($)
Table 11: Novartis AG: key financial ratios
Table 12: Pharmstandard OJSC: key facts
Table 13: Pharmstandard OJSC: key financials ($)
Table 14: Pharmstandard OJSC: key financials (RUB)
Table 15: Pharmstandard OJSC: key financial ratios
Table 16: Sanofi SA: key facts
Table 17: Sanofi SA: key financials ($)
Table 18: Sanofi SA: key financials (€)
Table 19: Sanofi SA: key financial ratios
Table 20: Russia size of population (million), 2009–13
Table 21: Russia gdp (constant 2000 prices, $ billion), 2009–13
Table 22: Russia gdp (current prices, $ billion), 2009–13
Table 23: Russia inflation, 2009–13
Table 24: Russia consumer price index (absolute), 2009–13
Table 25: Russia exchange rate, 2009–13

LIST OF FIGURES

Figure 1: Russia pharmaceuticals market value: $ billion, 2009–13
Figure 2: Russia pharmaceuticals market geography segmentation: % share, by value, 2013
Figure 3: Russia pharmaceuticals market share: % share, by value, 2013
Figure 4: Russia pharmaceuticals market value forecast: $ billion, 2013–18
Figure 5: Forces driving competition in the pharmaceuticals market in Russia, 2013
Figure 6: Drivers of buyer power in the pharmaceuticals market in Russia, 2013
Figure 7: Drivers of supplier power in the pharmaceuticals market in Russia, 2013
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2013
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2013
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2013
Figure 11: Bayer AG: revenues & profitability
Figure 12: Bayer AG: assets & liabilities
Figure 13: Novartis AG: revenues & profitability
Figure 14: Novartis AG: assets & liabilities
Figure 15: Pharmstandard OJSC: revenues & profitability
Figure 16: Pharmstandard OJSC: assets & liabilities
Figure 17: Sanofi SA: revenues & profitability
Figure 18: Sanofi SA: assets & liabilities
OTC Pharmaceuticals in Russia US$ 350.00 Aug, 2013 · 33 pages
The Pharmaceutical Market: Russia US$ 1,295.00 Jan, 2013 · 97 pages

Ask Your Question

Pharmaceuticals in Russia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: